Karavilagenin D TN4380
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Karavilagenin D exhibits inhibitory effects on skin-tumor promotion in an in vivo two-stage mouse skin carcinogenesis test based on 7,12-dimethylbenz[a]anthracene (DMBA) as initiator, and with TPA as a promoter. It exhibits inhibition effect against human
CAS nr:
934739-29-4
Purity:
98%
Molecular Weight:
470,7
SMILES:
C[C@H](C\C=C\C(C)(C)O)[C@H]1CC[C@@]2(C)[C@@H]3C=C[C@@]45OC(=O)[C@]3(CC[C@]12C)[C@@H]4CC[C@H](O)C5(C)C
Formula:
C30H46O4
Pathway:
Others
Target:
Others
